AU2001287028A1 - Combined estrogen blockade of the breast with exemestane and raloxifene - Google Patents
Combined estrogen blockade of the breast with exemestane and raloxifeneInfo
- Publication number
- AU2001287028A1 AU2001287028A1 AU2001287028A AU8702801A AU2001287028A1 AU 2001287028 A1 AU2001287028 A1 AU 2001287028A1 AU 2001287028 A AU2001287028 A AU 2001287028A AU 8702801 A AU8702801 A AU 8702801A AU 2001287028 A1 AU2001287028 A1 AU 2001287028A1
- Authority
- AU
- Australia
- Prior art keywords
- exemestane
- raloxifene
- breast
- combined estrogen
- blockade
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 title 1
- 210000000481 breast Anatomy 0.000 title 1
- 229940011871 estrogen Drugs 0.000 title 1
- 239000000262 estrogen Substances 0.000 title 1
- 229960000255 exemestane Drugs 0.000 title 1
- 229960004622 raloxifene Drugs 0.000 title 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65767000A | 2000-09-08 | 2000-09-08 | |
| US09/657,670 | 2000-09-08 | ||
| PCT/US2001/027308 WO2002020000A2 (en) | 2000-09-08 | 2001-09-04 | Combined estrogen blockade of the breast with exemestane and raloxifene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001287028A1 true AU2001287028A1 (en) | 2002-03-22 |
Family
ID=24638159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001287028A Abandoned AU2001287028A1 (en) | 2000-09-08 | 2001-09-04 | Combined estrogen blockade of the breast with exemestane and raloxifene |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040009962A1 (en) |
| EP (1) | EP1315483A2 (en) |
| JP (1) | JP2004508325A (en) |
| AR (1) | AR034142A1 (en) |
| AU (1) | AU2001287028A1 (en) |
| PE (1) | PE20020466A1 (en) |
| WO (1) | WO2002020000A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040186185A1 (en) * | 1998-05-07 | 2004-09-23 | Steiner Mitchell S. | Method for treatment and chemoprevention of prostate cancer |
| GB0120147D0 (en) * | 2001-08-17 | 2001-10-10 | Metris Therapeutics Ltd | Treatment method |
| WO2003017973A1 (en) * | 2001-08-31 | 2003-03-06 | Pantarhei Bioscience B.V. | A method of treating benign gynaecological disorders and a drug delivery vehicle for use in such a method |
| US20080249183A1 (en) * | 2001-11-29 | 2008-10-09 | Steiner Mitchell S | Treatment of androgen-deprivation induced osteoporosis |
| GB0129457D0 (en) * | 2001-12-10 | 2002-01-30 | Astrazeneca Ab | Method of treatment |
| AU2003261233A1 (en) * | 2002-07-25 | 2004-02-16 | Massachusetts Institute Of Technology | Steroid modulators in the treatment of peripheral nerve sheath tumors |
| WO2006114702A2 (en) * | 2005-04-25 | 2006-11-02 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor |
| US20060270641A1 (en) * | 2005-05-31 | 2006-11-30 | Steiner Mitchell S | Method for chemoprevention of prostate cancer |
| GB0813628D0 (en) * | 2008-07-25 | 2008-09-03 | Arrow Int Ltd | Stable coated anti-cancer agent |
| EP3274719B1 (en) | 2015-03-25 | 2021-02-24 | The Board of Trustees of the Leland Stanford Junior University | Single cell analysis using secondary ion mass spectrometry |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000038719A1 (en) * | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
-
2001
- 2001-08-21 AR ARP010103968A patent/AR034142A1/en not_active Application Discontinuation
- 2001-09-04 WO PCT/US2001/027308 patent/WO2002020000A2/en not_active Ceased
- 2001-09-04 AU AU2001287028A patent/AU2001287028A1/en not_active Abandoned
- 2001-09-04 JP JP2002524485A patent/JP2004508325A/en not_active Withdrawn
- 2001-09-04 EP EP01966522A patent/EP1315483A2/en not_active Withdrawn
- 2001-09-04 US US10/363,244 patent/US20040009962A1/en not_active Abandoned
- 2001-09-06 PE PE2001000898A patent/PE20020466A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002020000A2 (en) | 2002-03-14 |
| AR034142A1 (en) | 2004-02-04 |
| PE20020466A1 (en) | 2002-06-06 |
| US20040009962A1 (en) | 2004-01-15 |
| WO2002020000A3 (en) | 2003-02-27 |
| JP2004508325A (en) | 2004-03-18 |
| EP1315483A2 (en) | 2003-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3731600A (en) | Composition and structures made therefrom | |
| AU2505200A (en) | Multithreaded hdl logic simulator | |
| HUP0200898A2 (en) | Derivatives of venlafaxine and methods of preparing and using the same | |
| AU3692900A (en) | Atomic frequency standard | |
| IL150908A0 (en) | Single phase gels and methods for the preparation thereof | |
| IL161105A0 (en) | Estrogen/gestagen combination preparation and application thereof | |
| AU2001273074A1 (en) | Combinations of ssri and estrogenic agents | |
| AU7907300A (en) | Novel combination of loteprednol and antihistamines | |
| GB9924351D0 (en) | Immunomodulation methods and compositions | |
| AU8967998A (en) | Antibiotic-ligand conjugates and methods of use thereof | |
| IL149715A0 (en) | MICROBIAL 9α-HYDROXYLATION OF STEROIDS | |
| AU2001287028A1 (en) | Combined estrogen blockade of the breast with exemestane and raloxifene | |
| AU2002217841A1 (en) | Neuroactive steroid derivatives and methods of use | |
| IL146465A0 (en) | Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods | |
| AU2982000A (en) | Preparation of 9-hydrocarbyl-9-phosphabicyclononanes | |
| AU2001264863A1 (en) | Preparation of fagopyritols and uses therefor | |
| AU1660201A (en) | Biglycan and related therapeutics and methods of use | |
| AU7740100A (en) | Efficient implementation of multiprecision arithmetic | |
| AU6152700A (en) | Novel isoforms of the human estrogen receptor-alpha | |
| AU2001278963A1 (en) | Muo-conopeptides and their use as local anesthetics | |
| AU5632500A (en) | Cancer associated antigens and uses therefor | |
| AU2567599A (en) | Anti-ccr1 antibodies and methods of use therefor | |
| AU2001268903A1 (en) | Hexaglucal compound and the use and the methods of preparing them | |
| AU7673900A (en) | Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof | |
| AU2003600A (en) | External steroid preparation |